Larimar Therapeutics Inc (LRMR NASDAQ) stock market data APIs
$3.9215
0(0%)
as of September 15, 2025
Try our APIs with
free plan!
Larimar Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.
Prev. Close
3.9215
Open
3.9222
High
4.1367
Low
3.8436
52 wk Range
1.61-9.5
Market Cap
336 M
Shares Outstanding
85 590 K
EPS
-0.41
Beta
0.915
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Larimar Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Larimar Therapeutics Inc data using free add-ons & libraries
Get Larimar Therapeutics Inc Fundamental Data
Larimar Therapeutics Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -108 210 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-05
- EPS/Forecast: -0.4803
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Larimar Therapeutics Inc News
New
TNA: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily Small Cap Bull 3X Shares (Symbol: TNA) where we have de...
Larimar Beats Q2 Loss Estimates
Key Points GAAP EPS loss of $0.41 in Q2 2025 beat analyst expectations for a larger loss of $0.48 per share. R&D expenses (GAAP) rose 19% to $23.4 million in Q2 2025 compared to Q2 2024, primarily du...
Larimar Therapeutics GAAP EPS of -$0.41 beats by $0.07
* Larimar Therapeutics press release [https://seekingalpha.com/pr/20200727-larimar-therapeutics-reports-second-quarter-2025-financial-results] (NASDAQ:LRMR [https://seekingalpha.com/symbol/LRMR]): Q...
Insider Activity Recap: Top Buys and Sells from Monday, August 4, 2025
This article summarizes the most significant insider buying and selling activities reported for US stocks on Monday, August 4, 2025. Top Insider Buys: CVB Financial Corp (NASDAQ:CVBF): Director Ge...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
